Study in older and younger non-valvular atrial fibrillation patients with type 2 diabetes receiving rivaroxaban or warfarin
Latest Information Update: 31 Jan 2022
At a glance
- Drugs Rivaroxaban (Primary) ; Warfarin (Primary)
- Indications Atrial fibrillation; Embolism; Stroke
- Focus Adverse reactions; Therapeutic Use
Most Recent Events
- 31 Jan 2022 New trial record
- 14 Dec 2021 Results presented at the 63rd American Society of Hematology Annual Meeting and Exposition